AGAlasdair Gray

Alasdair Gray

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alasdair Gray has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Fiona Clare Sampson

    Sheffield Centre for Health and Related Research, School of Medicine and Population Health, University of Sheffield, Sheffield, United Kingdom

    2 shared publications
  • Moyra Masson

    From the Royal Infirmary of Edinburgh, Department of Emergency Medicine (A.G., M.M.), Edinburgh, United Kingdom; University of Sheffield, Medical Care Research Unit, School of Health & Related Research (S.G., J.N., F.S.), Sheffield, United Kingdom; University of Edinburgh, Department of Cardiology (D.E.N.), Edinburgh, United Kingdom; Leeds Teaching Hospitals Trust, Department of Respiratory Medicine (M.E.), Leeds, United Kingdom; York Hospitals National Health Service Foundation Trust,...

    2 shared publications
  • Steve Goodacre

    From the Royal Infirmary of Edinburgh, Department of Emergency Medicine (A.G., M.M.), Edinburgh, United Kingdom; University of Sheffield, Medical Care Research Unit, School of Health & Related Research (S.G., J.N., F.S.), Sheffield, United Kingdom; University of Edinburgh, Department of Cardiology (D.E.N.), Edinburgh, United Kingdom; Leeds Teaching Hospitals Trust, Department of Respiratory Medicine (M.E.), Leeds, United Kingdom; York Hospitals National Health Service Foundation Trust,...

    2 shared publications
  • A Stevenson

    Emergency Department, Southern General Hospital, Glasgow, UK

    1 shared publication
  • Anita K. Simonds

    Sleep and Ventilation Unit, Royal Brompton and Harefield NHS Foundation Trust, London, UK

    1 shared publication
  • Anthony De Soyza

    22Population Health Sciences Institute, Newcastle University, Newcastle Upon Tyne, UK

    1 shared publication

Latest Publications

  • Open Access

    RECOVERY- Respiratory Support: Respiratory Strategies for patients with suspected or proven COVID-19 respiratory failure; Continuous Positive Airway Pressure, High-flow Nasal Oxygen, and standard care: A structured summary of a study protocol for a randomised controlled trial

    by Gavin D. Perkins, Keith Couper, Bronwen Connolly, J. Kenneth Baillie, Judy M. Bradley, Paul Dark, Anthony De Soyza, Ellen Gorman, Alasdair Gray, Louisa Hamilton, et al.

    Objective: The trial objective is to determine if Continuous Positive Airway Pressure (CPAP) or High-Flow Nasal Oxygen (HFNO) is clinically effective compared to standard oxygen therapy in patients with confirmed or suspected COVID-19. Trial design: Adaptive (group-sequential), parallel group, pragmatic, superiority randomised controlled, open-label, multi-centre, effectiveness trial. Participants: The trial is being conducted across approximately 60 hospitals across England, Wales, Scotland, and Northern Ireland. Inpatients at participating hospitals are eligible to participate if they have respiratory failure with suspected or proven COVID-19, and meet all of the inclusion criteria and none of the exclusion criteria. Inclusion criteria: 1) Adults ≥ 18 years; 2) Admitted to hospital with suspected or proven COVID-19; 3) Receiving oxygen with fraction of inspired oxygen (FiO2) ≥0.4 and peripheral oxygen saturation (SpO2) ≤94%; and 4) Plan for escalation to tracheal intubation if needed. Exclusion criteria: 1) Planned tracheal intubation and mechanical ventilation imminent within 1 hour; 2) Known or clinically apparent pregnancy; 3) Any absolute contraindication to CPAP or HFNO; 4) Decision not to intubate due to ceiling of treatment or withdrawal of treatment anticipated; and 5) Equipment for both CPAP and HFNO not available. Intervention and comparator: Intervention one: Continuous positive airway pressure delivered by any device. Set-up and therapy titration is not protocolised and is delivered in accordance with clinical discretion. Intervention two: High-flow nasal oxygen delivered by any device. Set-up and therapy titration is not protocolised and is delivered in accordance with clinical discretion. Comparator group: Standard care- oxygen delivered by face mask or nasal cannula (excluding the use of continuous positive airway pressure or high-flow nasal oxygen). Set-up and therapy titration is not protocolised and is delivered in accordance with clinical discretion. Intervention delivery continues up to the point of death, tracheal intubation, or clinical determination that there is no ongoing need (palliation or improvement). Main outcomes: The primary outcome is a composite outcome comprising tracheal intubation or mortality within 30 days following randomisation. Secondary outcomes include tracheal intubation rate, time to tracheal intubation, duration of invasive ventilation, mortality rate, time to mortality, length of hospital stay, and length of critical care stay. Randomisation: Participants are randomised in a 1:1:1 ratio to receive either continuous positive airway pressure, high-flow nasal oxygen or standard care. Due to the challenging environment of study delivery, a specific intervention may not always be available at the hospital site. The study uses two integrated randomisation systems to allow, where required, the site to randomise between all three interventions, between CPAP and standard care, and between HFNO and standard care. System integration ensures maintenance of balance between interventions. Randomisation is performed using a telephone-based interactive voice response system to maintain allocation concealment. The randomisation sequence was computer-generated using the minimisation method. Participant randomisation is stratified by site, gender (M/F), and age (=50 years). Blinding (masking): The nature of the trial interventions precludes blinding of the researcher, patient and clinical team. Primary and secondary outcomes are all objective outcomes, thereby minimising the risk of detection bias. Numbers to be randomised (sample size): 4002 participants (1334 to be randomized to each of the three study arms) Trial Status: Current protocol: Version 4.0, 29th May 2020. Recruitment began on April 6, 2020 and is anticipated to be complete by April 5, 2021. The trial has been awarded Urgent Public Health status by the National Institute of Health Research on 13th April 2020. Trial registration: ISRCTN, ISRCTN16912075. Registered 6th April 2020, http://www.isrctn.com/ISRCTN16912075 Full protocol: The full protocol (version 4.0, 29th May 2020) is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol. The study protocol has been reported in accordance with the Standard Protocol Items: Recommendations for Clinical Interventional Trials (SPIRIT) guidelines (Additional file 2).


  • Open Access

    Diuretic, opiate and nitrate use in severe acidotic acute cardiogenic pulmonary oedema: analysis from the 3CPO trial

    by A. Gray, S. Goodacre, M. Seah, S. Tilley

    Background: Drug treatments for acute cardiogenic pulmonary oedema (ACPO) have not been rigorously evaluated and recent observational data suggests some agents are related to poorer outcome.


  • The Development of a Simple Risk Score to Predict Early Outcome in Severe Acute Acidotic Cardiogenic Pulmonary Edema

    by Alasdair Gray, Steve Goodacre, Jon Nicholl, Moyra Masson, Fiona Sampson, Mark Elliott, Steve Crane, Dave E. Newby

    Background— Acute cardiogenic pulmonary edema is a common medical emergency with high early mortality. Initial clinical assessment would benefit from accurate mortality prediction. We aimed to develop a simple clinical score based on presenting characteristics that would predict 7-day mortality in patients with acute cardiogenic pulmonary edema. Methods and Results— We used data from patients recruited to the 3CPO trial (a pragmatic multicenter trial comparing continuous positive airway pressure, noninvasive positive pressure ventilation, and standard oxygen therapy in emergency department patients with acute cardiogenic pulmonary edema) to investigate the association between baseline characteristics and 7-day mortality. Factors associated with mortality ( P P P =0.003), systolic blood pressure ( P P =0.02) as the only independent predictors of 7-day mortality. These were weighted and used to develop a risk score ranging from 0 (7-day mortality, 1.9%; 95% CI, 0.8 to 4.5) to 7 (7-day mortality, 100%; 95% CI, 34.2 to 100). Receiver operator characteristic analysis demonstrated good risk prediction with a c-statistic of 0.794 (95% CI, 0.745 to 0.843). A simplified 3-point score with no weighting had a c-statistic of 0.754 (95% CI, 0.701 to 0.807). Conclusions— A simple clinical score based on age, systolic blood pressure, and the ability to obey commands predicts early mortality in patients with acute cardiogenic pulmonary edema. Clinical Trial Registration— clinicaltrials.gov Identifier: ISRCTN077448447.


  • Top Cited Papers

    Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema

    by Alasdair Gray, Steve Goodacre, David E. Newby, Moyra Masson, Fiona Sampson, Jon Nicholl

    Noninvasive ventilation (continuous positive airway pressure [CPAP] or noninvasive intermittent positive-pressure ventilation [NIPPV]) appears to be of benefit in the immediate treatment of patients with acute cardiogenic pulmonary edema and may reduce mortality. We conducted a study to determine whether noninvasive ventilation reduces mortality and whether there are important differences in outcome associated with the method of treatment (CPAP or NIPPV).


  • Critical care in the emergency department: patient transfer

    by M J G Dunn, C L Gwinnutt, A J Gray

    Transfers can be primary or secondary. In the UK, primary transfers to hospital from a prehospital site of illness or injury are commonly the responsibility of the ambulance service. These systems may be supported or supplemented by doctors. Secondary transfers include both intrahospital and interhospital transport, and are inevitable for all critically ill patients in the emergency department unless they die during their time in the resuscitation room. Emergency departments may also receive interhospital critical care transfers as an intermediate destination.


  • Use of non-invasive ventilation in UK emergency departments

    by J Browning, B Atwood, A Gray, on behalf of the 3CPO trial group

    To describe the current use of non-invasive ventilation in UK emergency departments. A structured questionnaire was sent to all UK emergency departments assessing 25,000 new patients annually. 222 of 233 departments completed the questionnaire. 148 currently use non-invasive ventilation (NIV). Most used NIV for either cardiogenic pulmonary oedema (n = 128) or chronic obstructive pulmonary disease (n = 115). Only 49 departments have protocols for NIV use and 23 audited practice. NIV is commonly used in UK emergency departments. Practices vary significantly. One solution would be the development of guidelines on when and how to use NIV in emergency medicine practice.


  • Open Access

    Emergency department organisation of critical care transfers in the UK

    by A Stevenson, C Fiddler, M Craig, A Gray

    Objectives: Transport of the critically ill patient to or from the emergency department (ED) is a frequent occurrence. This study was designed to determine whether UK EDs currently have appropriate equipment, monitoring, staff training systems, and processes of care for transportation of the critically ill patient. Methods: A postal questionnaire regarding ED transfer patients was sent to 247 UK EDs, followed by repeat mailing and telephone follow up of non-responders. Results: In total, 139 EDs (56%) responded. An estimated 20–30 critically ill patients are transferred from and Conclusions: This study highlights inadequacies in provision of equipment and monitoring during interhospital transfer from the ED. Training and processes of care for transport of the critically ill are also suboptimum. Many departments are currently reviewing these processes to formalise and improve transfer training procedures and protocols.


  • Open Access

    Secondary transport of the critically ill and injured adult

    by A Gray, S Bush, S Whiteley

    There is significant interest in the secondary transport of the critically ill and injured. High profile cases entailing the long distance transfer of patients have highlighted the lack of availability of critical care beds and appropriate systems for transferring this patient group. These and other issues have culminated in the release of Comprehensive Critical Care by the Department of Health in 2000. It has been shown that a large number of critical care transfers originate in the emergency department. The transportation of patients has not traditionally been part of the core curriculum of emergency medicine specialists in the UK. It is imperative that clinicians have an understanding of the issues surrounding transportation of the critically ill and injured. This should include appreciation of the local and regional organisational frameworks implemented for this patient group. This review describes the core issues relevant to emergency medicine relating to the transportation of the critically ill and injured.